See also this year's filing and all EDGAR filings for this company.
PDF Report 0001311241_2013_Intermolecular_INC.pdf
Logs
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001311241')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001311241, Intermolecular INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 37,398,000 |
| 1 | LiabilitiesNonCurrent | 146,000 |
| 2 | remainder_Liabilities | 624,000 |
| 3 | AssetsCurrent | 89,605,000 |
| 4 | AssetsNonCurrent | 191,000 |
| 5 | IntangibleAssets | 6,671,000 |
| 6 | PropertyPlantAndEquipmentNet | 24,058,000 |
| 7 | remainder_Assets | 3,160,000 |
| 8 | ResearchAndDevelopmentExpense | 21,839,000 |
| 9 | SellingGeneralAndAdministrativeExpense | 16,301,000 |
| 10 | AmortizationOfIntangibleAssets | 0 |
| 11 | remainder_Expenses | 28,454,000 |
| 12 | remainder_Revenues | 66,827,000 |
| 13 | remainder_NetIncome | -989,000 |
| 14 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 38,168,000 |
| 1 | Assets | 123,685,000 |
| 2 | Expenses | 66,594,000 |
| 3 | Revenues | 66,827,000 |
| 4 | StockholdersEquity | 85,517,000 |
| 5 | NetIncome | -756,000 |
| 6 | ComprehensiveNetIncome | -756,000 |
| 7 | BaseVar | 338,321,650 |
| 8 | EconomicCapitalRatio | 2.44 |
Edgar->Model Mapping
Feature Distribution
